Chinese pharma firm Nuance raises $181m co-led by GT Fund, RTW

Chinese pharma firm Nuance raises $181m co-led by GT Fund, RTW

Chinese specialty pharmaceutical firm Nuance Biotech has raised $181 million in a Series D round of financing to advance the R&D of the firm’s existing drug candidates and to explore new potential products.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter